Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Ulcerative Colitis
Clinical trial register · Germany

Ulcerative Colitis Trials in Germany, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Germany and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5062 matching records held by the registry are in this view. Synced 10 Nov 2026, 03:18 UTC
5062
Studies in scope
all four open statuses
2869
Recruiting now
open to new participants
983
Lead sponsors
across recruiting studies
Top sites
Ulm 16 Berlin 13 Kiel 11 Leipzig 10 Halle 9
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AbbVie7 Eli Lilly and Company5 Sanofi3 Merck Sharp & Dohme LLC2 Gilead Sciences2 Abivax S.A.2 Spyre Therapeutics, Inc.2 Alfasigma S.p.A.2 Pfizer2 Takeda1 Janssen Biotech, Inc.1 Janssen Research & Development, LLC1 Andreas Stallmach1 AnaptysBio, Inc.1 Genentech, Inc.1
Site location
Ulm16 Berlin13 Kiel11 Leipzig10 Halle9 Dachau8 Hanover8 Munich8 Frankfurt am Main7 Hamburg7 Heidelberg6 Erlangen5 Minden5 Tübingen4 Ludwigshafen3 Brandenburg an der Havel3 Duisburg3 Münster3 Brandenburg3 Frankfurt3 Freiburg im Breisgau3 Potsdam3 Regensburg2 Augsburg2 Kassel2 Lüneburg2 Saarbrücken2 Dresden2 Tostedt2 Ludwigshafen am Rhein2 Mainz2 Remscheid2 Dessau Roblau1 Cottbus1 Jerichow1 Jena1 Bamberg1 Fulda1 Winnenden1 Essen1 Nürtingen1 Pforzheim1 Aachen1 Wriezen1 Schwerin1 Ahaus1 Bochum1 Grevenbroich1 Liepzig1 Bonn-Duisdorf1 Neuss1 Grünwald1 Amberg1 Darmstadt1 Wolfsburg1 Herne1
All 56 locations
Target enrolment
to

Ulcerative Colitis trials in Germany

33 of 5062 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Germany
Start
By invitation
Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD
NCT07652294Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis, Colitis, Ulcerative
DrugsSPY001·SPY002·SPY003
Spyre Therapeutics, Inc.
Phase 2
645
Ulm
2026-06-08
Recruiting
Merck Sharp & Dohme LLC
Phase 2
100
Ulm, Brandenburg
2026-03-24
Recruiting
Sanofi
Phase 3
751
Tübingen, Ulm, Leipzig, Halle, Kiel, Berlin, Minden
2026-01-16
Recruiting
Eli Lilly and Company
Phase 2
252
Berlin, Dachau, Erlangen, Regensburg, Ulm
2025-11-10
Recruiting
Sanofi
Phase 3
980
Wolfsburg, Halle, Berlin, Herne, Kiel, Leipzig, Minden, Ulm
2025-10-08
Recruiting
Genentech, Inc.
Phase 2
224
Frankfurt am Main
2025-09-29
Recruiting
Alfasigma S.p.A.
Phase 3
80
Aachen, Leipzig, Mainz, Tübingen
2025-09-29
Recruiting
AbbVie
Phase 3
120
Cottbus, Kassel, Münster
2025-07-28
Active, closed
Sanofi
Phase 2
105
Minden, Kiel, Ulm
2025-07-07
Recruiting
Eli Lilly and Company
Phase 3
350
Frankfurt, Grevenbroich, Halle, Hanover, Leipzig, Potsdam
2025-06-26
Active, closed
AbbVie
Phase 3
573
Freiburg im Breisgau, Ulm, Dachau, Erlangen, Regensburg, Frankfurt am Main, Essen, Minden
2025-06-17
Recruiting
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
NCT07012395Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis, Colitis, Ulcerative
DrugsSPY001·SPY002·SPY003
Spyre Therapeutics, Inc.
Phase 2
645
Berlin, Brandenburg an der Havel, Dachau, Frankfurt am Main, Kiel, Leipzig, Munich, Ulm
2025-05-27
Recruiting
AbbVie
Observational
200
Heidelberg, Potsdam, Wriezen, Tostedt, Hanover, Schwerin, Ahaus, Bochum
2025-02-27
Active, closed
Eli Lilly and Company
Phase 2
143
Augsburg, Berlin, Brandenburg an der Havel, Duisburg, Frankfurt am Main, Halle, Hamburg, Hanover
2024-10-10
Active, closed
Takeda
Phase 2
213
Frankfurt am Main, Hamburg, Heidelberg, Kiel, Ludwigshafen, Tübingen, Ulm
2024-03-29
Active, closed
Gilead Sciences
Phase 2
228
Dresden, Halle, Kiel, Ulm
2024-03-27
Active, closed
AbbVie
Phase 2
156
Ulm, Munich, Ludwigshafen am Rhein, Leipzig, Kiel, Hamburg
2024-03-23
Active, closed
Gilead Sciences
Phase 2
176
Berlin, Hanover, Kiel, Liepzig, Ulm
2023-12-05
Active, closed
AnaptysBio, Inc.
Phase 2
132
Berlin, Brandenburg, Dachau, Duisburg, Erlangen, Hamburg, Kiel, Ulm
2023-12-04
Active, closed
AbbVie
Phase 3
122
Munich, Münster, Leipzig, Berlin
2023-11-06
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,109
Ulm, Dachau, Munich, Frankfurt am Main, Hanover, Lüneburg, Duisburg, Minden
2023-10-25
Active, closed
Alfasigma S.p.A.
Observational
509
Grünwald, Amberg, Dachau, Hamburg, Heidelberg, Kiel, Leipzig, Münster
2023-06-12
Active, closed
Transfer of FRozen Encapsulated Multidonor Stool Filtrate for Active Ulcerative COlitis
NCT03843385Ulcerative Colitis, Inflammatory Bowel Diseases
Andreas Stallmach
Phase 3
84
Jena, Bamberg, Berlin, Dresden, Erlangen, Frankfurt, Freiburg im Breisgau, Fulda
2023-01-31
Active, closed
ABTECT - Maintenance
NCT05535946Ulcerative Colitis
DrugObefazimod
Abivax S.A.
Phase 3
1,116
Freiburg im Breisgau, Heidelberg, Nürtingen, Pforzheim, Tübingen, Ulm, Erlangen, Munich
2023-01-16
Active, closed
AbbVie
Observational
400
Heidelberg, Winnenden, Augsburg, Dachau, Munich, Brandenburg an der Havel, Potsdam, Tostedt
2022-10-20
Active, closed
AbbVie
Observational
785
Dachau, Darmstadt, Frankfurt am Main, Kassel, Remscheid, Ludwigshafen am Rhein, Saarbrücken, Leipzig
2022-08-15
Active, closed
Abivax S.A.
Phase 2
203
Frankfurt, Halle, Hanover
2021-12-03
Active, closed
Pfizer
Phase 3
118
Munich
2021-08-12
Recruiting
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
NCT04844606Ulcerative Colitis, Ulcerative Colitis Chronic, Inflammatory Bowel Diseases, Crohn's Disease
DrugMirikizumab
Eli Lilly and Company
Phase 3
150
Mainz, Munich
2021-05-26
Active, closed
Janssen Research & Development, LLC
Phase 2/3
1,064
Berlin, Halle, Hanover, Jerichow, Lüneburg, Saarbrücken, Ulm
2019-09-26
Active, closed
Pfizer
Phase 3
896
Berlin, Bonn-Duisdorf, Neuss, Remscheid
2019-09-05
Active, closed
Eli Lilly and Company
Phase 3
1,058
Berlin, Brandenburg, Halle, Hamburg, Hanover, Ludwigshafen
2018-07-18
Active, closed
Janssen Biotech, Inc.
Observational
535
Berlin, Dessau Roblau, Halle, Hamburg, Heidelberg, Kiel, Leipzig, Ludwigshafen
2016-12-16
Rows per page Showing 1–33 of 33
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a German investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 November 2026. https://priyalifescience.com/clinical-trials-germany/condition/ulcerative-colitis

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Germany and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,062 studies in total at the last sync on 10 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 33 of those studies listing the condition Ulcerative Colitis.

How many Ulcerative Colitis trials are recruiting in Germany?

11 of the 33 studies on this page are recruiting new participants as of the 10 Nov 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 21 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Ulcerative Colitis), 33 studies
PhaseStudiesRecruitingShare
Phase 314642.4%
Phase 213439.4%
Observational5115.2%
Phase 2/3103%

Most active sponsors

Lead sponsors with the most studies (Ulcerative Colitis)
Lead sponsorStudiesRecruiting
AbbVie72
Eli Lilly and Company53
Sanofi32
Abivax S.A.20
Alfasigma S.p.A.21
Gilead Sciences20
Merck Sharp & Dohme LLC21
Pfizer20
Spyre Therapeutics, Inc.21
AnaptysBio, Inc.10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.